691 related articles for article (PubMed ID: 19840150)
1. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
[TBL] [Abstract][Full Text] [Related]
2. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
[TBL] [Abstract][Full Text] [Related]
3. Asenapine review, part II: clinical efficacy, safety and tolerability.
Citrome L
Expert Opin Drug Saf; 2014 Jun; 13(6):803-30. PubMed ID: 24793161
[TBL] [Abstract][Full Text] [Related]
4. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
[TBL] [Abstract][Full Text] [Related]
5. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
[TBL] [Abstract][Full Text] [Related]
6. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
[TBL] [Abstract][Full Text] [Related]
7. Asenapine: a new antipsychotic option.
Henry JM; Fuller MA
J Pharm Pract; 2011 Oct; 24(5):447-51. PubMed ID: 22156709
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder.
McIntyre RS
Expert Rev Neurother; 2010 May; 10(5):645-9. PubMed ID: 20420486
[TBL] [Abstract][Full Text] [Related]
9. Asenapine: a synthesis of efficacy data in bipolar mania and schizophrenia.
McIntyre RS; Wong R
Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):217-20. PubMed ID: 22182459
[TBL] [Abstract][Full Text] [Related]
10. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
Citrome L
Int J Clin Pract; 2011 Mar; 65(3):330-40. PubMed ID: 21199198
[TBL] [Abstract][Full Text] [Related]
11. Asenapine: a clinical review of a second-generation antipsychotic.
Stoner SC; Pace HA
Clin Ther; 2012 May; 34(5):1023-40. PubMed ID: 22494521
[TBL] [Abstract][Full Text] [Related]
12. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
Chwieduk CM; Scott LJ
CNS Drugs; 2011 Mar; 25(3):251-67. PubMed ID: 21323396
[TBL] [Abstract][Full Text] [Related]
13. Asenapine: a review of acute and extension phase data in bipolar disorder.
McIntyre RS
CNS Neurosci Ther; 2011 Dec; 17(6):645-8. PubMed ID: 20950326
[TBL] [Abstract][Full Text] [Related]
14. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.
Szegedi A; Zhao J; van Willigenburg A; Nations KR; Mackle M; Panagides J
BMC Psychiatry; 2011 Jun; 11():101. PubMed ID: 21689438
[TBL] [Abstract][Full Text] [Related]
15. Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2019 Oct; 73(10):e13397. PubMed ID: 31355510
[TBL] [Abstract][Full Text] [Related]
16. Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review.
Stepanova E; Grant B; Findling RL
Paediatr Drugs; 2018 Apr; 20(2):121-134. PubMed ID: 29170943
[TBL] [Abstract][Full Text] [Related]
17. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Citrome L
Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
[TBL] [Abstract][Full Text] [Related]
18. Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder.
Findling RL; Landbloom RL; Szegedi A; Koppenhaver J; Braat S; Zhu Q; Mackle M; Chang K; Mathews M
J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1032-41. PubMed ID: 26598478
[TBL] [Abstract][Full Text] [Related]
19. Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 29024264
[TBL] [Abstract][Full Text] [Related]
20. Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant--what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2013 Nov; 67(11):1089-104. PubMed ID: 24016209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
